Paula SoteropoulosChief Executive Officer at Akcea Therapeutics
Paula Soteropoulos joined Akcea Therapeutics as President and Chief Executive Officer upon its formation in January 2015. Prior, she was at Moderna Therapeutics as the Cardiometabolic Business General Manager and SVP of Strategic Alliances. Prior to Moderna, she spent 21 years at Genzyme where she was instrumental in advancing new products from discovery through clinical development and commercialization with significant roles driving strategy, sales and marketing and business development. Additionally, Paula led manufacturing process development, strategic capacity planning and supply chain development. Paula serves on the Board of Directors of uniQure and on the Advisory Board of the Tufts University Chemical/Biological Engineering Department. She holds her B.S. and Master’s degrees in Chemical and Biochemical Engineering from Tufts University and earned an executive management certificate from Darden School of Business, University of Virginia. Paula is a past honoree of Mass High Tech’s Women to Watch.